UNICREDIT BANK/PUT/ELI LILLY & CO/800/0.1/18.12.24 Share Price

Warrant

DE000HD5URB6

Market Closed - BOERSE MUENCHEN 01:10:28 28/06/2024 am IST
2.88 EUR +2.13% Intraday chart for UNICREDIT BANK/PUT/ELI LILLY & CO/800/0.1/18.12.24
Current month-48.11%
1 month-50.00%
Date Price Change
27/24/27 2.88 +2.13%
26/24/26 2.82 -0.70%
25/24/25 2.84 -5.65%
24/24/24 3.01 -8.51%
21/24/21 3.29 -0.60%

Real-time BOERSE MUENCHEN

Last update June 28, 2024 at 01:10 am IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer UniCredit UniCredit
WKN HD5URB
ISINDE000HD5URB6
Date issued 23/05/2024
Strike 800 $
Maturity 18/12/2024 (174 Days)
Parity 10 : 1
Emission price 6.18
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 5.98
Lowest since issue 2.8
Delta-0.22x
Omega 6.828
Premium15.27x
Gearing30.61x
Moneyness 0.8800
Difference Strike -109 $
Difference Strike %-13.63%
Spread 0.07
Spread %2.49%
Theoretical value 2.775
Implied Volatility 32.96 %
Total Loss Probability 70.87 %
Intrinsic value 0.000000
Present value 2.775
Break even 770.30 €
Theta-0.1x
Vega0.17x
Rho-0.08x

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
909 USD
Average target price
860.5 USD
Spread / Average Target
-5.33%
Consensus